Loading fund overlap…
19 of 149 unique stocks in common · Jaccard: 12.8%
A weighted portfolio overlap of 22.24% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹22.24 is allocated to the exact same companies at the same relative proportions. The schemes share 19 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 5.11% in Franklin India Multi-Factor Fund and 8.46% in Tata Nifty500 Multicap India Manufacturing 50-30-20 Index Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Franklin | in Tata |
|---|---|---|
| Reliance IndustriesPetroleum Products | 5.11% | 8.46% |
| Eicher MotorsAutomobiles | 1.53% | 2.09% |
| Bharat ElectronicsAerospace & Defense | 1.47% | 3.12% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.42% | 4.04% |
| Tata Motors Passenger VehiclesAutomobiles | 1.30% | 1.75% |
| Hindalco IndustriesNon - Ferrous Metals | 1.23% | 3.46% |
| Hero MotoCorpAutomobiles | 1.23% | 1.98% |
| Maruti Suzuki IndiaAutomobiles | 1.03% | 3.65% |
| Tata SteelFerrous Metals | 1.00% | 3.64% |
| LupinPharmaceuticals & Biotechnology | 0.99% | 1.71% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.98% | 1.68% |
| Bharat ForgeAuto Components | 0.92% | 1.62% |
| Mahindra & MahindraAutomobiles | 0.90% | 5.77% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 0.81% | 1.24% |
| Polycab IndiaIndustrial Products | 0.56% | 1.56% |
| Hindustan Petroleum CorporationPetroleum Products | 0.45% | 1.18% |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | 0.45% | 1.07% |
| Natco PharmaPharmaceuticals & Biotechnology | 0.45% | 0.43% |
| Navin Fluorine InternationalChemicals & Petrochemicals | 0.42% | 1.25% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.